AZN three-lens brief
Evidence-based stock research on AZN. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Moved -2.93% yesterday. · 50-day MA below 200-day MA (death-cross regime); price below both.
- Moved -2.93% yesterday.
- 50-day MA below 200-day MA (death-cross regime); price below both.
- Analyst mean target $221.09 — 28% above current (10 analysts).
- Earnings scheduled 2026-07-27.
AZN closed at $173.26 (-2.93%) as of 2026-07-10. Market cap: $268.71B. P/E (trailing) 26.1. Price is below the 50-day MA and below the 200-day MA. Positives: analyst mean target $221.09 — 28% above current (10 analysts).. Concerns: moved -2.93% yesterday.; 50-day MA below 200-day MA (death-cross regime); price below both.. Last quarter: Revenue $15.29B, net income $3.08B, free cash flow $6.56B. Watching for: 2026-07-27 earnings release (16 days out).
Why three lenses on AZN, not one.
A single reasoning model has blind spots it doesn’t know about. We examine AZNacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/AZN" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath AZN brief"></iframe>